| Literature DB >> 27177826 |
Laureen C Colis1, Seth B Herzon2.
Abstract
(-)-Lomaiviticin A (1) is a cytotoxic bacterial metabolite that induces double-strand breaks in DNA. Here we show that the cytotoxicity of (-)-lomaiviticin A (1) is synergistically potentiated in the presence of VE-821 (7), an inhibitor of ataxia telangiectasia and Rad3-related protein (ATR). While 0.5nM 1 or 10μM 7 alone are non-lethal to K562 cells, co-incubation of the two leads to high levels of cell kill (81% and 94% after 24 and 48h, respectively). Mechanistic data indicate that cells treated with 1 and 7 suffer extensive DNA double-strand breaks and apoptosis. These data suggest combinations of 1 and 7 may be a valuable chemotherapeutic strategy.Entities:
Keywords: Cancer; Chemotherapy; DNA; Lomaiviticin; Natural product; Synergism
Mesh:
Substances:
Year: 2016 PMID: 27177826 PMCID: PMC4899226 DOI: 10.1016/j.bmcl.2016.04.090
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823